The U.S. kicked off an an unprecedented inoculation campaign this week with a COVID-19 vaccine from Pfizer and its German partner BioNTech. Another vaccine from Moderna, which was co-developed with ...
Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.
COLUMBIA, S.C. — A South Carolina Senate Medical Affairs subcommittee heard more than an hour of conflicting testimony ...
Pfizer says kid-size doses of its COVID-19 vaccine are safe and nearly 91% effective at preventing infections in elementary school children. Details of the study were posted online Friday. FDA ...
Drug maker Pfizer says it's planning to start testing its COVID-19 vaccine on children as young as 12. This will be the first coronavirus vaccine trial to include children in the United States. The ...
The Hearty Soul on MSN
Study Suggests Possible Link Between Pfizer COVID-19 Vaccine and Vision-Related Eye Conditions
Public interest has recently turned to the human eye and the Pfizer COVID-19 Vaccine. Two peer-reviewed papers have helped ...
A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...
This year’s updated COVID-19 vaccines have been approved by the U.S. Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...
The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results